Tirzepatide 10mg

Dual incretin-pathway research peptide (GLP-1 / GIP) supplied as lyophilized tirzepatide for laboratory receptor studies. Third-party tested. Batch COA and endotoxin report included. Not for human or animal consumption, injection, or any clinical use.

$109.00

10 mg lyophilized · one vial

Label claim Tirzepatide 10 mg

Assayed content 11.66 mg · 99.86% total purity

Endotoxin 0.50 EU/mg · Pass (limit 35.00)

Documentation Third-party COA + endotoxin page

Request this research material

RESEARCH USE ONLY. This material is sold strictly for in-vitro laboratory research, analytical method development, and other non-clinical scientific applications. It is not a drug, supplement, or cosmetic. It has not been evaluated by the FDA. No statements on this page are dosing guidance or claims of safety or efficacy for human use.

What is in the vial

Labeled identity

Pep TideZ 808 Tirzepatide / GLP-2 T 10mg. Vertical mark: RESEARCH USE ONLY.

Assayed content

Label claim 10 mg. Third-party assay measured 11.66 mg/unit at 99.865% analyte purity (99.86% total purity).

Intended research context

Lipidated dual-agonist research peptide for laboratory GLP-1/GIP pathway studies. Not supplied for personal administration.

Molecular identity

Reference structures for catalog framing, COA matching, and laboratory documentation. For Research Use Only. Not for human consumption.

Tirzepatide

Role. Synthetic lipidated dual GLP-1 / GIP receptor research ligand.

Sequence. 39-amino-acid backbone with Aib residues and C20 fatty-diacid conjugation on Lys.

Molecular formula. C₂₂₅H₃₄₈N₄₈O₆₈

Molecular weight. ≈ 4813.5 Da

Framing: dual incretin-pathway research tool for in-vitro receptor and signaling studies.

Purity, COA & endotoxin documentation

Figures from the third-party Certificate of Analysis and endotoxin page for Tirzepatide 10mg.

Test	Method / source	Result	Status
Total purity	Peptide panel (TM-13)	99.86%	Reported
Tirzepatide purity	% on COA	99.865%	Reported
Tirzepatide content	mg/unit on COA	11.66 mg/unit	Reported
Endotoxin	LAL · limit 35.00 EU/mg	0.50 EU/mg	Pass
Matrix / presentation	COA header	Peptide · vial	As reported

Matching COA and endotoxin pages ship with the vial. Supplier identity is redacted for their protection.

Label claim is 10 mg; assayed mass on this batch is 11.66 mg. The laboratory header lists sample type as “Vial (Injectable).” That is the lab’s matrix field only. This product is sold as Research Use Only and is not offered for injection or any human use. Supplier identity is redacted for their protection. Unredacted laboratory identifiers are available to qualified research purchasers upon request.

COA page 1 — purity

99.86% total purity. Tirzepatide 11.66 mg/unit.

COA page 2 — endotoxin

0.50 EU/mg against a 35.00 EU/mg limit. Status: Pass.

Shipping from Honolulu

Protected pack-out

Insulated packaging with ice packs as standard for this lyophilized research material. Discrete, trackable U.S. shipping from Oahu.

Threshold

Free shipping on qualifying orders of $100 or more, consistent with the current Pep TideZ 808 store policy.

Documents in the box

Vial, RUO labeling, and the matching COA / endotoxin report, supplier identity redacted.

Research buyer FAQ

Is this for human use?

No. All Pep TideZ 808 products are Research Use Only. They are not intended for human or animal consumption, injection, diagnostic use, therapeutic use, or any form of personal administration.

Who may purchase?

Purchasers must be at least 21 and represent that they are a qualified researcher, laboratory professional, or authorized representative of a legitimate research organization, and that the material will be used only for lawful laboratory research.

What testing is provided?

This batch: 99.86% total purity, 11.66 mg assayed, endotoxin 0.50 EU/mg (Pass, limit 35.00 EU/mg).